Stempoint Capital LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Stempoint Capital LP disclosed 76 US equity positions worth $495.9m in its Q3 2025 13F filing. The largest position was ROIV at 12.8% of the reported book, followed by QURE and SRRK. Against the Q2 2025 filing, it opened 20 new positions, added to 18 and reduced 12 among the top 50 holdings.
What did Stempoint Capital LP own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ROIV ROIVANT SCIENCES LTD | Healthcare | 12.8% | $63.5m | 4,197,187 | 597% | added |
| 2 | QURE UNIQURE NV | 6.1% | $30.5m | 522,155 | -9% | reduced | |
| 3 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 5.5% | $27.0m | 726,204 | 38% | added |
| 4 | IMVT IMMUNOVANT INC | Healthcare | 5.2% | $25.6m | 1,589,580 | 22% | added |
| 5 | DNLI DENALI THERAPEUTICS INC | Healthcare | 5.1% | $25.2m | 1,734,659 | 145% | added |
| 6 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 4.2% | $21.0m | 1,366,205 | -42% | reduced |
| 7 | CNTA CENTESSA PHARMACEUTICALS PLC | 3.2% | $15.9m | 655,385 | -48% | reduced | |
| 8 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 3.1% | $15.4m | 2,110,152 | 134% | added |
| 9 | BHVN BIOHAVEN LTD | Healthcare | 3.1% | $15.3m | 1,017,311 | 482% | added |
| 10 | CDTX CIDARA THERAPEUTICS INC | 2.9% | $14.6m | 152,325 | -43% | reduced | |
| 11 | ABVX ABIVAX SA | 2.8% | $14.1m | 166,273 | 89% | added | |
| 12 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 2.0% | $10.1m | 371,825 | 124% | added |
| 13 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.9% | $9.2m | 91,444 | -48% | reduced |
| 14 | ARGX ARGENX SE | Healthcare | 1.9% | $9.2m | 12,465 | – | new |
| 15 | SRZN SURROZEN INC | 1.9% | $9.2m | 713,463 | 4% | added | |
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.7% | $8.7m | 185,380 | – | new |
| 17 | RZLT REZOLUTE INC | 1.7% | $8.6m | 917,630 | 42% | added | |
| 18 | GHRS GH RESEARCH PLC | 1.6% | $7.8m | 545,275 | 441% | added | |
| 19 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 1.6% | $7.8m | 411,893 | 100% | added |
| 20 | VTGN VISTAGEN THERAPEUTICS INC | 1.6% | $7.7m | 2,488,685 | 3% | added | |
| 21 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.6% | $7.7m | 192,295 | – | new |
| 22 | ALKS ALKERMES PLC | Healthcare | 1.5% | $7.2m | 241,637 | -31% | reduced |
| 23 | CELC CELCUITY INC | Healthcare | 1.4% | $6.8m | 136,710 | – | new |
| 24 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.3% | $6.6m | 127,435 | 133% | added |
| 25 | INSM INSMED INC | Healthcare | 1.3% | $6.3m | 43,419 | -29% | reduced |
| 26 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.2% | $6.0m | 474,612 | – | new |
| 27 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.2% | $6.0m | 158,112 | -75% | reduced |
| 28 | AKERO THERAPEUTICS INC | 1.2% | $5.8m | 121,410 | 4% | added | |
| 29 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 1.0% | $5.1m | 39,072 | – | new |
| 30 | RNAGBP AVIDITY BIOSCIENCES INC | 1.0% | $5.0m | 114,053 | – | new | |
| 31 | NEWAMSTERDAM PHARMA COMPANY | 0.9% | $4.3m | 150,573 | -1% | reduced | |
| 32 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.8% | $4.2m | 359,470 | – | new |
| 33 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.8% | $3.8m | 8,207 | -84% | reduced |
| 34 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.8% | $3.8m | 276,884 | – | new |
| 35 | INCY INCYTE CORP | Healthcare | 0.7% | $3.7m | 43,754 | – | new |
| 36 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.7% | $3.6m | 129,335 | – | new |
| 37 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.6% | $3.2m | 350,710 | – | new |
| 38 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.6% | $3.2m | 47,954 | 186% | added |
| 39 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.6% | $3.0m | 53,201 | – | new |
| 40 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.6% | $3.0m | 15,149 | – | new |
| 41 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.6% | $3.0m | 188,999 | 372% | added |
| 42 | HROW HARROW INC | 0.6% | $2.8m | 57,619 | – | new | |
| 43 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.6% | $2.7m | 839,669 | -30% | reduced |
| 44 | EQ EQUILLIUM INC | 0.6% | $2.7m | 1,908,935 | – | new | |
| 45 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.5% | $2.6m | 6,264 | – | new |
| 46 | CGON CG ONCOLOGY INC | Healthcare | 0.5% | $2.5m | 63,019 | – | new |
| 47 | QQQ INVESCO QQQ TR | 0.5% | $2.3m | 3,797 | – | new | |
| 48 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.4% | $2.2m | 186,614 | – | new | |
| 49 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.4% | $2.1m | 245,378 | 18% | added |
| 50 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.4% | $2.0m | 166,461 | -17% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.